The global Prepacked Chromatography Columns Market is estimated to be valued at US$ 307.6 Mn or Million in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Prepacked chromatography columns are pre-packed with chromatographic media in order to simplify separations and shorten process development and scale-up times. The prepacked format minimizes method development time and potential operator error during packing.
Market key trends:
One of the key trends in the prepacked chromatography columns market is the increasing demand from the pharmaceutical industry. The biopharmaceutical industry relies heavily on chromatography for downstream processing of biotherapeutics. Prepacked columns help streamline purification processes and ensure consistency in purifications. They reduce method development timelines and optimize resource utilization for cGMP manufacture of biologics. Their plug-and-play format is well suited for automation and continuous processing. This is driving the prepacked chromatography columns market.
Market key trends:
The prepacked chromatography columns market has been witnessing significant growth, driven by the increasing demand for protein purification applications. The growing focus on therapeutic antibody production for biologics has boosted the adoption of prepacked columns. These columns provide consistency in performance, scalability for process development and manufacturing, and a reduction in errors during chromatography runs. Moreover, the technological advancements in prepacked columns, including the introduction of miniature columns and monolithic media columns, have improved throughput and yield.
SWOT Analysis
Strength: Prepacked columns offer consistency in performance and results. They reduce errors and save time during chromatography runs.
Weakness: Prepacked columns have a higher initial cost compared to packing chromatography columns in-house.
Opportunity: Growing biologics production and therapeutic antibody demand provide an opportunity for column manufacturers. Technological advancements are expanding applications.
Threats: Price wars among established players can threaten pricing models. Short product life cycles require continued innovation.
Key Takeaways
The global Prepacked Chromatography Columns Market Size was valued at US$ 307.6 Mn in 2023 and is expected to reach over US$ 531.7 Mn by 2030, expanding at a CAGR of 7.9% during the forecast period.
The increasing production of biologics and therapeutic antibodies is driving the demand for prepacked columns for large-scale purification processes. The North American region currently dominates the market owing to presence of leading players and a well-established biopharmaceutical industry in the US and Canada.
Key players operating in the prepacked chromatography columns market are Thermo Fisher Scientific Inc., Cytiva, Sartorius AG, Repligen Corporation, Merck Millipore, VWR International, Llc. (Avantor), Phenomenex Inc., Agilent Technologies, Inc., Knauer Wissenschaftliche Geräte GmbH, Hawach Scientific Co., Ltd., Purolite, BioServUK Ltd., Astrea Bioseparations Ltd., Daisogel USA (Osaka Soda Co., Ltd.), Shimadzu Corporation, Waters Corporation, Showa Denko K.K, Harvard Bioscience, Inc, Tosoh Corporation, Geno Technology Inc., USA., Santai Science, Biotage, ChromaNik Technologies, Inc., Proxcys B.V., GALAK Chromatography Technology Co., Ltd., and Daicel Corporation.